ArticleNeuroradiology2026
Pathological signatures of white matter lesions in multiple sclerosis versus stroke: a synthetic MRI study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate whether quantitative synthetic MRI (SyMRI) parameters can differentiate non-specific white matter lesions (nsWMLs) in patients with multiple sclerosis (MS) and ischemic stroke, and to assess differences in normal-appearing white matter (NAWM) between these groups.
methodsThirty MS patients and nineteen ischemic stroke patients underwent standardized MRI including SyMRI. Three lesion categories were analyzed: typical MS lesions (MSL), non-specific lesions in MS (nsWML-MS), and non-specific lesions in stroke (nsWML-S). SyMRI-derived parameters (R1, R2, proton density, and myelin content) were extracted from each region of interest (ROI), and one ROI was placed in NAWM per patient. Group differences were evaluated using non-parametric tests. Logistic regression models, both unadjusted and age-adjusted, assessed predictors of MS diagnosis.
resultsTypical MS lesions showed lower myelin content and R1 and higher proton density than nsWML-MS (all p < 0.0001). Compared with nsWML-S, nsWML-MS demonstrated lower myelin content and higher proton density (p < 0.05), while R1 and R2 values did not differ. NAWM differences between MS and stroke emerged only after age adjustment. Age alone discriminated MS from stroke (AUC 0.83), with modest improvement when NAWM measures were added (AUC 0.86).
conclusionSyMRI captures both lesion-specific and diffuse NAWM differences between MS and stroke. Age strongly influences quantitative white matter measures, and adjusting for age reveals subtle NAWM pathology in MS. SyMRI may support differential diagnosis in patients with ambiguous white matter lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.